Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beyond Celiac is a leading non-profit organization and venture philanthropy fund dedicated to accelerating the development of treatments and a cure for celiac disease. Through its investment arm, Beyond Celiac Investments, the organization provides strategic funding and patient-centric insights to biotechnology companies developing innovative disease-modifying therapies. Their mission is to move beyond the current standard of care—a strict gluten-free diet—by supporting research into immune tolerance, restorative medicine, and advanced diagnostics. Beyond Celiac also manages "Go Beyond Celiac," a comprehensive patient registry that provides critical real-world data for clinical trial recruitment and academic research. By bridging the gap between the patient community and the pharmaceutical industry, the organization plays a vital role in de-risking drug development for celiac disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beyond Celiac Investments.